Skip to main content

ADVERTISEMENT

Bioresorbable stents

Conference Insights
03/06/2017

Cath Lab Digest talks with Ramon L. Varcoe, MBBS, MS, PhD, FRACS, 
Associate Professor of Vascular Surgery, University of New South Wales; 
Vascular Surgeon, Prince of Wales Hospital, Sydney, Australia.

From the VEITH Symposium, November 15-19, 2016, New York, New York. 

Cath Lab Digest talks with Ramon L. V...
This was a first-in-human study. We began working with this new investigational device approximately four years ago. The study itself was a single-center study and is a prospective cohort that we have been performing for slightly less than...
This was a first-in-human study. We began working with this new investigational device approximately four years ago. The study itself was a single-center study and is a prospective cohort that we have been performing for slightly less than...
This was a first-in-human study....
03/06/2017
Cath Lab Digest
Clinical Editor's Corner
09/05/2016

Morton J. Kern, MD, with commentary from David G. Rizik, MD, FACC, FSCAI, Founder and Medical Director, Scottsdale Heart Group, Scottsdale, Arizona.

Morton J. Kern, MD, with commentary f...
I thought it worthwhile to review the role of intravascular imaging for the routine use of BVS in order to achieve best results. 
I thought it worthwhile to review the role of intravascular imaging for the routine use of BVS in order to achieve best results. 
I thought it worthwhile to...
09/05/2016
Cath Lab Digest
CRF-SKIRBALL Interventional Innovation Corner
01/31/2016

The Skirball Center for Innovation (SCI) at the Cardiovascular Research Foundation (CRF) Interventional Innovation Corner is headed by section editor Juan F. Granada, MD, Executive Director and Chief Innovation Officer; Assistant Professor of Medicine, Columbia University College of Physicians and Surgeons, New York City, New York.

This month, Antonio Colombo, MD, Director of Cardiovascular Interventions at San Raffaele Scientific Institute, Columbus Hospital, Milan, Italy, shares his thoughts and experience with bioresorbable vascular scaffolds.

The Skirball Center for Innovation (S...
Bioresorbable scaffolds (BRS) are emerging as an alternative approach to metallic DES due to their ability to mechanically support coronary arteries in the early phase post intervention, followed by complete absorption of the scaffold over...
Bioresorbable scaffolds (BRS) are emerging as an alternative approach to metallic DES due to their ability to mechanically support coronary arteries in the early phase post intervention, followed by complete absorption of the scaffold over...
Bioresorbable scaffolds (BRS)...
01/31/2016
Cath Lab Digest